Device Authority expands enterprise reach through IoT security partnership

Tern plc

Device Authority has strengthened its enterprise positioning through a strategic partnership with Xalient, a provider of identity-led cybersecurity services and managed solutions. The collaboration will see Xalient integrate Device Authority’s KeyScaler platform into its IoT security offering, with the aim of helping enterprise customers protect connected devices across complex IT, IoT and operational technology environments.

This places Device Authority’s technology within a managed security model that is designed for large organisations facing rising operational, regulatory and cyber risk. As connected devices become more embedded in sectors such as energy, utilities, manufacturing, healthcare and critical infrastructure, enterprises are under pressure to secure assets that are often distributed, long-lived and difficult to manage through traditional security tools.

The partnership addresses a practical challenge for customers: manual approaches to device identity, credential management and access control are increasingly difficult to scale. In large deployments, unmanaged or poorly governed devices can create visibility gaps, compliance issues and operational exposure. Device Authority’s KeyScaler platform is designed to automate identity lifecycle management for IoT and OT devices, from secure onboarding and credential provisioning through to certificate rotation, decommissioning and policy-driven access control.

Xalient’s role adds an important route-to-market dimension. By delivering the joint capability through its managed “as-a-service” security model, Xalient can support customers that want to improve IoT and OT security without adding complexity to internal teams.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Search